Cargando…
Reply to ‘Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects’
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120895/ https://www.ncbi.nlm.nih.gov/pubmed/30177696 http://dx.doi.org/10.1038/s41467-018-05678-4 |
_version_ | 1783352344092606464 |
---|---|
author | Sykes, David A. Lane, J. Robert Szabo, Monika Capuano, Ben Javitch, Jonathan A. Charlton, Steven J. |
author_facet | Sykes, David A. Lane, J. Robert Szabo, Monika Capuano, Ben Javitch, Jonathan A. Charlton, Steven J. |
author_sort | Sykes, David A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6120895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61208952018-09-05 Reply to ‘Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects’ Sykes, David A. Lane, J. Robert Szabo, Monika Capuano, Ben Javitch, Jonathan A. Charlton, Steven J. Nat Commun Correspondence Nature Publishing Group UK 2018-09-03 /pmc/articles/PMC6120895/ /pubmed/30177696 http://dx.doi.org/10.1038/s41467-018-05678-4 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Sykes, David A. Lane, J. Robert Szabo, Monika Capuano, Ben Javitch, Jonathan A. Charlton, Steven J. Reply to ‘Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects’ |
title | Reply to ‘Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects’ |
title_full | Reply to ‘Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects’ |
title_fullStr | Reply to ‘Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects’ |
title_full_unstemmed | Reply to ‘Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects’ |
title_short | Reply to ‘Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects’ |
title_sort | reply to ‘antipsychotics with similar association kinetics at dopamine d(2) receptors differ in extrapyramidal side-effects’ |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120895/ https://www.ncbi.nlm.nih.gov/pubmed/30177696 http://dx.doi.org/10.1038/s41467-018-05678-4 |
work_keys_str_mv | AT sykesdavida replytoantipsychoticswithsimilarassociationkineticsatdopamined2receptorsdifferinextrapyramidalsideeffects AT lanejrobert replytoantipsychoticswithsimilarassociationkineticsatdopamined2receptorsdifferinextrapyramidalsideeffects AT szabomonika replytoantipsychoticswithsimilarassociationkineticsatdopamined2receptorsdifferinextrapyramidalsideeffects AT capuanoben replytoantipsychoticswithsimilarassociationkineticsatdopamined2receptorsdifferinextrapyramidalsideeffects AT javitchjonathana replytoantipsychoticswithsimilarassociationkineticsatdopamined2receptorsdifferinextrapyramidalsideeffects AT charltonstevenj replytoantipsychoticswithsimilarassociationkineticsatdopamined2receptorsdifferinextrapyramidalsideeffects |